SCHEMBL135885

SCHEMBL135885

COc1ccc(C(=O)c2c(N)sc3c2CCCC3)cc1OC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.65
KMT2A Q03164 4/20 0.65
FLT3 P36888 3/20 0.65
RECQL P46063 2/20 0.65
MAPT P10636 6/20 0.64
ALDH1A1 P00352 5/20 0.64
TDP1 Q9NUW8 1/20 0.62
HPGD P15428 3/20 0.61
LMNA P02545 1/20 0.61
GAA P10253 1/20 0.61
TP53 P04637 1/20 0.55
ADORA1 P30542 1/20 0.55
KDM4E B2RXH2 3/20 0.55
HSD17B10 Q99714 2/20 0.55
USP2 O75604 1/20 0.55
ALOX15 P16050 1/20 0.54
MAPK1 P28482 1/20 0.54
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL141125 0.91 MAPT (0.66) MEN1KMT2AFLT3RECQLMAPT
SCHEMBL4060800 0.83 TDP1 (0.71) MEN1KMT2AFLT3MAPTALDH1A1
SCHEMBL3777713 0.82 TDP1 (0.69) MEN1KMT2AFLT3MAPTALDH1A1
SCHEMBL135664 0.81 ALDH1A1 (0.73) MEN1KMT2AFLT3MAPTALDH1A1
SCHEMBL4060747 0.81 TDP1 (0.67) MEN1KMT2AMAPTALDH1A1TDP1
SCHEMBL134640 0.80 MEN1 (0.67) MEN1KMT2AFLT3RECQLMAPT
SCHEMBL136844 0.80 TDP1 (0.74) MEN1KMT2AFLT3RECQLMAPT
SCHEMBL8289393 0.80 MAPT (0.65) MEN1KMT2AMAPTALDH1A1TDP1
SCHEMBL135616 0.79 MAPT (0.63) MEN1KMT2AFLT3RECQLMAPT
SCHEMBL135571 0.79 TDP1 (0.73) MEN1KMT2ARECQLMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430029-B1 THIENO[2,3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2018-01-10 EP disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS CISTIM LEUVEN VZW (BE) 2014-10-02 US disclosed
US-8785638-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-07-22 US disclosed
EP-2430029-A1 THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2012-03-21 EP disclosed
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed
WO-2010130842-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS MEN1 4548/4885KMT2A 2903/4885FLT3 2523/4885
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS MEN1 4548/4885KMT2A 2903/4885FLT3 2523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.